Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6

Overview of attention for article published in Frontiers in Molecular Biosciences, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 43 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,960 followers.

1-10-2021: China's 11 pro-Actemra COVID-19 studies: Binqing Fu, Pan Luo, Jianbo Tian, Dongsheng Wang, Xiaoling Xu, Yun Yang, Jia Zeng, Chi Zhang, Xuhan Zhang, Hong Zhao, Kai-Lian Zheng. Today, Pan Li has become China's 12th, the world's 138th, pro-Actemra

03 May 2021

Reply Repost Favourite

New article: Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6 https://t.co/m5fP8QDiZI #coronavirus #COVID19 #2019ncov https://t.co/JJdw9DLKwP

03 May 2021

Reply Repost Favourite

New Research: Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6 https://t.co/DNqKKpC9ST #MolBioSci

20 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.